[Frontiers in Bioscience 14, 112-129, January 1, 2009]

Neural-immune system interactions in Xenopus

Kevin S. Kinney1, Nicholas Cohen2

1 Department of Biology, DePauw University, Greencastle, IN 46135, 2Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. A case for comparative psychoneuroimmunology
4. Current understanding
4.1. Innervation
4.2. Transmitter regulation of immunity
4.3. Endocrine effects on immunity
4.3.1. Hypophyseal axis hormones
4.3.2. Seasonal effects on immunity
4.3.3. Metamorphosis and immunity
4.4. Heat shock proteins and neural-immune system interactions
5. Speculations, applications, and future directions
5.1. The amphibian decline problem: applied comparative psychoneuroimmunology
6. Acknowledgements
7. References

1. ABSTRACT

In Xenopus, as in mammals, there is a functionally significant bidirectional communication between the neuroendocrine and immune systems. In this review, we describe the evidence for the neural innervation of Xenopus lymphoid organs, review the effects of neurotransmitter and hormone manipulations on measures of immunity, and discuss the role of hormones on immunological changes during metamorphosis. We also speculate as to the phylogenetic significance of these data, and outline possible areas of future research

2. INTRODUCTION

The existence of a robust functionally significant bidirectional communication between neuroendocrine and immune systems has progressed from a "fringe" hypothesis to a well-established and well-accepted fact (1-4). This evolution of an idea has been fueled by research from many different perspectives and disciplines, resulting in a new discipline known by several names that include psychoneuroimmunology, neuroendocrinimmunology, neuroimmunomodulation, or more simply, neural-immune system interactions. As with many newly established areas of inquiry, psychoneuroimmunology has "progressed" from phenomenology to detailed mechanistic studies. As might be expected, the overwhelming majority of studies pertaining to neural-immune interactions has been conducted with mammals, chiefly rodents and primates, and it is in these species that our understanding of mechanisms is most developed. While an exhaustive review of the literature of this research area is quite beyond the scope of this paper (5, 6), it is worthwhile to outline six major lines of evidence for bidirectional neural-immune communication, as demonstrated in mammals.

1. Various stimuli (generally lumped under the term "stressors") can elicit behavioral responses ("stress responses") with associated central and peripheral neuroendocrine and autonomic nervous system changes that can alter both laboratory measures of immune responses and the health of the organism following immune challenge (7) or challenge with a pathogen (8). Such stressors can be physical (e.g., footshock, restraint) or psychosocial (e.g., differential housing or handling in animals; bereavement or taking examinations in humans (2, 9-11). It has even been shown that clinically relevant immunopharmacologic effects and immune responses can be conditioned classically (12-14).

2. Lymphoid tissues are innervated by autonomic nerve fibers in patterns that extend beyond just a close association with the vasculature. (6, 15, 16). Using both sucrose-potassium phosphate-glyoxylic acid (SPG) histofluorescence for catecholamines (described in (17)) and immunohistochemistry for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis, Felten and Olschowka (18) have demonstrated sympathetic innervation of the mouse spleen, with fibers almost exclusively confined to the lymphopoietic white pulp. While the case for direct neural input is most clear for the catecholamines, there is also circumstantial evidence for neuropeptidergic synaptic transmission, implicating vasoactive intestinal peptide (VIP), cholecystokinin (CCK), substance P (SP), and neuropeptide Y (NPY), some of which may be co-localized with monoamines (6, 19-22). One noteworthy neurotransmitter system which does not seem to be involved in peripheral neuroimmune transmission is the parasympathetic cholinergic (acetylcholine) system (6).

3. Cells of the immune system (i.e., lymphocytes, monocytes/macrophages, and natural killer cells) express receptors for neurotransmitters, neuropeptides, and hormones (23, 24). While the best known of the hormone-immune interactions involves hormones of the hypothalamo-pituitary-adrenal (HPA) axis and the resulting immunomodulatory effects of elevated levels of glucocorticoids (25), many other pituitary-derived hormones have also been implicated in immune modulation (26-29).

4. Leukocytes respond to altered concentration of the ligands for such receptors, whether pharmacologically (that is, by direct addition of the ligand) or via manipulation of the endogenous system (e.g., sympathetic nervous system ablation) with alterations in function (24, 30-32). Ablation of sympathetic nervous system (SNS) activity has been associated with changes in splenocyte proliferation in response to either polyclonal mitogen stimulation or antigen-specific stimulation (31, 32), as well as alterations in serum immunoglobulin levels from mice immunized after sympathectomy.

5. Leukocytes also produce neuropeptides and hormones, thus allowing for bidirectional communication as well as autocrine regulation (33-35). Such products have been demonstrated to be associated with altered activity and metabolism in the CNS during an immune response (36), including activation of the HPA axis, thereby allowing for a complete loop in communication pathways (37). Some of these CNS changes resulting from an immune response are associated with the well-known "sickness behaviors:" fever (which may be a behavioral response in ectotherms see (38)), loss of appetite, and changes in slow-wave sleep (39).

6. Conversely, neuroendocrine cells can both produce and respond to molecules classically assigned to immune regulation (i.e., cytokines) (40-43). Microglia in the CNS produce several proinflammatory cytokines, and can change their production profiles depending on activation state (44, 45).

3. A CASE FOR COMPARATIVE PSYCHONEUROIMMUNOLOGY

After having arrived at a point where such bidirectional communications can be examined in detail, and whose consequences are at least beginning to be understood, the time is ripe for understanding the phylogenetic history, and hence the evolutionary significance, of such interactions. The extensive "common vocabulary" of information molecules and their receptors used by both the neuroendocrine and immune systems argues for a long history of interaction between the two systems, and is also supportive of a long-term adaptive significance for neural-immune crosstalk. Our understanding of the phylogenesis of such interactions and significance would be enhanced greatly through exploration of the existence of homologues of the mammalian system in other vertebrate (and even invertebrate) species.

A review of comparative studies in psychoneuroimmunology confirms the existence of a long phylogenetic history of interactions between the neuroendocrine and immune systems. These interactions even appear to predate the emergence of the vertebrate adaptive immune system. For example, hemocytes from several molluscan, annelid, and insect species exhibit immunoreactivity for, and functional responses to, a variety of vertebrate neuropeptides (5).

Among vertebrate classes, teleosts, amphibians, reptiles, and birds have all received at least an occasional examination for neural-immune communication. In all classes, such interactions have been demonstrated, although the methods involved and exact nature of the evidence (e.g., anatomical evidence of innervation of organs, demonstration of receptors on lymphocytes, stress effects on immunity, etc.) vary dramatically (reviewed in (5)). Although there has been a substantial amount of work in the area of comparative neural-immune interactions encompassing many species and all major vertebrate classes, no single nonmammalian species has yet emerged as a model for such studies, and no single nonmammalian species has been characterized by all the approaches used for mammals.

It can be argued justifiably that the class Amphibia mirrors a potentially pivotal transition in terms of immune function. The colonization of land is, at least loosely, associated with a substantial reorganization of the immune system, most likely in response to altered immunological challenges and selective pressures. If neural-immune crosstalk is adaptive for immune function, it seems logical to examine amphibians for important phylogenetic transitions in the development of such crosstalk.

The Amphibia are a highly diverse class of vertebrates in terms of their immune system as well as body plan and life history (46-48). Architecture of lymphoid tissues from representatives of the orders Urodela and Apoda resembles that of fish, whereas the organization of lymphoid tissue from the anuran species examined is more similar to that of mammals (49). Functionally, amphibian immune systems exhibit similar diversity. For example, relative to anurans, urodeles (salamanders) have a substantially delayed courses of antibody production and allograft rejection (50).

The typical anuran amphibian undergoes two distinct developmental periods; the first spans the periods of embryonic and larval life, the second, the hormonally driven transition from larval to adult life. From detailed studies with the South African clawed frog, Xenopus laevis, we know that this latter period is accompanied by a substantial remodeling of the immune system (reviewed in (51) and by Izutsu in this volume). Each period provides a window of opportunity for examining neural-immune communication in the context of the mammalian standard.

Historically, Xenopus has served as the primary model for immunologic studies of the Amphibia. In part, this is because both larval and adult stages are totally aquatic which facilitates experimentation before, during, and after metamorphosis. The popularity of this species for immunological research has led to a substantial array of reagents (monoclonal antibodies, molecular probes, etc.) and cell culture technologies. In turn, this has resulted in the immune system of Xenopus being the best characterized of any amphibian species (51, 52). Additionally, several cloned and inbred lines of Xenopus now exist (53), allowing for more fine-tuned analyses of immunity along the lines of those used so successfully in mice. It is not surprising, therefore, that, among amphibian species, Xenopus is also most thoroughly studied in terms of neural-immune interactions. To date, this work has involved primarily anatomic demonstration of neural innervation of lymphoid organs (54), effects of neurotransmitter and hormone manipulations on measures of immunity (55), and the role of hormones on immunological changes during metamorphosis (56).

4. CURRENT UNDERSTANDING

4.1. Innervation

Initial evidence of the potential for communication between the nervous and immune systems stemmed from observations of innervation of lymphoid organs. Interestingly, by the time studies demonstrating such innervation in mammals appeared in the late 1980s (18, 57), several studies revealing innervation in anuran amphibians had already been published (58, 59). This research not only demonstrated the presence of sympathetic nerve fibers in the spleen of Bufo marinus (58), but also direct contacts between nerve endings and lymphoid cells in the jugular body of Rana pipiens (59).

In Xenopus, the spleen is well-organized into morphologically distinct zones of red pulp and white pulp reminiscent of the pattern seen in mammals (49, 60). The pattern of neural innervation of the spleen is also similar to mammals. Xenopus splenic white pulp is innervated with noradrenergic nerve fibers (demonstrated by SPG histofluorescence as well as by TH immunohistochemistry) as well as with neuropeptide Y (NPY)- and substance P (SP)-containing fibers (54). Noradrenergic fibers are seen in association with the central artery, with varicosities extending into the parenchyma of the white pulp, and also in the boundary cell/perifollicular area where secreted neurotransmitter may come into contact with: B-cells and macrophages of the white pulp; nonlymphoid dendritic cells involved in trapping and retention of soluble antigen (60); and possibly the T-cells at the extreme boundary of the white pulp.

It is worth pointing out that this pattern of splenic innervation, while seemingly characteristic of adult anurans, is distinct from NE innervation patterns of representatives from other amphibian orders. Examination of the spleen of several species of salamanders revealed substantial innervation, but in a diffuse pattern of nerve fibers associated with the splenic reticular network (54). A lack of compartment-associated innervation in the salamander spleen is not unexpected, since the salamander spleen is not compartmentalized into lymphoid white pulp and erythropoietic red pulp. To complete the picture (to the degree possible in such a field), the Gymnophiona (apodan amphibians or caecilians) have splenic compartmentation somewhere between that of anurans and urodeles, with some white-pulp aggregations of lymphocytes (60). SPG histofluorescence staining revealed very low levels of innervation that is found both in association with the splenic vasculature and in remote areas of the spleen (54). Taken together, these comparisons suggest that changes in lymphoid organ organization across phylogeny have been paralleled by changes in sympathetic innervation.

A few studies have examined the ontogeny of splenic innervation during the larval and perimetamorphic life of Xenopus; these studies were conducted in an attempt to determine whether there are changes associated with the well-characterized immune system changes that occur during development (51). Interactions between development of innervation and immune system reorganization appear to be complex and dynamic as might be expected in such a rapidly changing system. Splenic innervation is observable as early as Nieuwkoop and Faber (61) larval stage 54 (62), with a drop in splenic NE levels (assessed by HPLC and SPG histofluorescence, (63)) at stage 58, a developmental point at which lymphocyte numbers and their mitogen responsiveness have also been reported to decrease (64). The adult pattern of innervation confined to white pulp then emerges at metamorphic climax (65). The appearance of this splenic innervation appears to be very sensitive to environmental conditions (e.g., animal density, temperature, etc. (62)). However, early larval thymectomy which renders animals T-deficient does not alter the development of normal innervation (66, 67). Prevention of overt metamorphosis by sodium perchlorate blockade (68) prevented the development of NA splenic innervation in some, but not all, tadpoles examined (62). Further, chemical removal of sympathetic innervation during larval life prior to the appearance of splenic compartmentation did not alter the subsequent appearance of distinct red and white pulp compartments (62).

A neuropharmacologic avenue for endocrine-immune interactions in the Xenopus thymus is also present, as implied by the work of Palmer and colleagues revealing several neuroactive peptides (CGRP, NPY, somatostatin, and SP) in the thymus of this species (see the article in this issue) as well as several other species (69); thus, there is no doubt a long phylogenetic history of thymus-neuroendocrine interactions that warrants further investigation.

4.2. Transmitter Regulation of Immunity

As with mammals, there is pharmacologic evidence that cells of the amphibian immune system express receptors for neuroendocrine transmitters/hormones. Radioligand studies have demonstrated the presence of specific, saturable beta adrenergic receptors (beta-AR) on splenocytes and activated peritoneal leukocytes from several species of amphibian; Xenopus, however, was not examined (70). The Plytycz lab had previously demonstrated the presence of muscarinic-type cholinergic receptors on anuran peritoneal leukocytes (71), but in light of the considerable literature indicating a lack of direct cholinergic effect on immunity in mammals (6), the functional significance (if any) of such receptors is unclear. Given that the status of cholinergic innervation of mammalian spleen was a matter of debate for some time, further investigation of cholinergic effects on amphibian lymphocytes is needed.

Hodgson et al. (72, 73) reported adrenergic receptor sensitivity of Xenopus antigen-binding splenocytes, as well as splenocytes from several other amphibian species. Alpha-AR stimulation decreased, whereas beta-AR stimulation increased the number of antigen-binding lymphocytes (thought to be T-cells by these investigators). In vitro phytohemagglutinin (PHA)-stimulated T-cell mitogenesis was reduced when splenocytes were co-cultured with a beta-AR agonist (10-10-10-12M isoproterenol).

The same group (74, 75) reported different effects of in vivo NE administration on in vitro antibody responses in Xenopus; these differences appear to be based on the thymus dependency of the response and the timing of immunization relative to NE administration. Chronic NE administration (by means of an implanted pellet) before antigen priming with a T-dependent antigen led to increased antibody productions, whereas NE exposure after priming had no demonstrable effect. Responses to T-independent antigens were studied using an acute injection of NE rather than a pellet. A reduced splenic anti-TNP antibody response was seen in splenocytes from frogs that had received an injection of NE at the time of immunization with TNP-LPS. Given that the route, timing, and duration of NE administration was varied in addition to the antigen type, we feel that no general conclusions can be put forward from these studies.

The same investigators also demonstrated effects of in vitro pharmacologic manipulation on antibody production. A low dose of NE (10-12M) or the beta-AR agonist, isoproteranol (10-12-10-15M) enhanced the production of anti-TNP antibody by splenocytes from animals primed in vitro with TNP-LPS, whereas treatment with the alpha-2 agonist clonidine (10-9-10-15M) resulted in a reduced response, an effect that was blocked by the alpha-antagonist, yohimbine.

In vitro stimulation of beta-AR (isoproterenol (ISO, a ß2-agonist) at 10-8-10-10M) was also reported to reduce PHA-stimulated T-cell mitogenesis (74). We have only been able to replicate this finding when we used much higher (i.e., supraphysiologic) concentrations of ISO (Fig 1). Given that the authors did not detail their culture methodology, we remain unable to provide any explanation for the disparity between the two reports.

Adrenergic effects on in vitro apoptosis of Xenopus splenocytes have also been reported (76). This effect was modulatory rather than direct: no AR agonist induced apoptosis over the 4-20 hour culture time; both alpha and beta AR stimulation altered the apoptosis of lymphocytes cultured with a calcium ionophore; alpha-AR stimulation (clonidine, and alpha-2 agonist) enhanced ionophore-induced apoptosis in 4-hour (but not 20-hour) cultures; and beta2-AR stimulation (ISO) diminished apoptosis in 4-hour cultures but increased apoptosis in 20-hour cultures. Whatever the underlying pathway (s), there appears to be some specificity for the agent used to induce apoptosis, as results differed when apoptosis was induced through culture with the synthetic glucocorticoid, dexamethasone (DEX); clonidine had no effect, and ISO enhanced the DEX-induced cell death at 4, but not 20 hours of culture.

One avenue for exploration of functional in vivo interactions between nervous and immune systems that has been used extensively in mammals has been the ablation of the SNS using the selective neurotoxin 6-hydroxydopamine (6-OHDA) to destroy catecholamine-containing nerve terminals. Administration of 6-OHDA leads to an immediate release of NE from sympathetic nerve terminals, followed by a profound, but transient, drop in NE levels until the terminals regenerate and normal levels reoccur (77). The immunological consequences of depletion of this sympathetic neurotransmitter are complex in that it has been associated with an enhancement of both polyclonal and antigen-driven in vitro proliferation of splenocytes from mice on the one hand (31, 32) and unaltered (78) or reduced (30, 79) responses to thymus-dependent (T-dependent) antigens on the other. Not only do these diverse real effects point out considerable interstrain variability of sympathectomy (SyX) on immune function (79) but they highlight the importance of other variables that include the nature and concentration antigen and the timing of SyX relative to antigen administration (80, 81).

Chemical sympathectomy is immunomodulatory in amphibians as well as in mammals, and has been used in a few experiments to examine the effects of sympathetic innervation on immune function in larval and adult Xenopus. Splenocytes from adult Xenopus that had been chemically SyX two days prior to sacrifice, reproducibly exhibit an increased proliferative response to the mitogens lipopolysaccharide (LPS), concanavalin A (Con A), and PHA (55). Increased in vitro proliferation has also been seen using keyhole limpet hemocyanin (KLH) to stimulate splenocytes from frogs that had been first sympathectomized and subsequently immunized with KLH (Figure 2).

Sympathectomy was reported to: reduce anti-hapten antibody responses to TNP-SRBC; enhance primary anti-hapten response when frogs were primed with TNP coupled to a T-independent carrier (74, 75); and have no effect on primary serum anti-KLH IgM in frogs immunized 2 days after SyX (Figure 3). These data indicate a complex relationship between SNS activity and the immune response that depends on the nature of the antigen. In recent studies from the Kinney lab, SyX frogs that had been immunized with KLH received a secondary challenge with KLH following a repeated 6-OHDA injection (on days 47 and 49). Serum anti-KLH IgM (Figure 3) and IgY (Figure 4) levels were elevated when compared to the appropriate controls. This may be the first examination, in any species, of the impact of SyX on secondary antibody responses.

In terms of cell-mediated immunity in mammals, investigations on the effects of 6-OHDA denervation on delayed-type hypersensitivity (DTH) responses (82) revealed that SyX of C3H/HeJ and BALB/c mice was associated with reduced ear swelling induced by antigen challenge of sensitized animals, an effect which was, at least in part, a result of reduced antigen-specific T-cell response. SyX mice exhibited reduced antigen-specific interleukin-2 (IL-2) production and cytotoxic T-lymphocyte activity by cells from draining lymph nodes (LN) harvested five days after contact sensitization.

In amphibians, a commonly used in vivo measure of cell mediated immunity is rejection of skin allografts (83). Chemical SyX two days before transplantation and repeated weekly during the course of the experiment to maintain denervation, had no effect on skin allograft rejection in Xenopus regardless of whether the host-donor disparity involved MHC plus minor histocompatibility (H) locus antigens or just minor H-antigens (Table 1). Further, there was no effect of SyX on the second-set rejection of grafts that differed from the cloned recipients only by minor H loci.

Metamorphosis in Xenopus is associated with an ease of tolerance induction of MHC identical but minor H-locus incompatible grafts transplanted during this period (see chapter by Izutsu in this volume). It is thought that such allotolerance is a reflection of the tolerance that must develop to new self-antigens that emerge during this transition from immunocompetent larva to immunocompetent adult. Chemical SyX also had no discernible effect on the development of tolerance of perimetamorphic animals to skin allografts from adult donors differing at only minor H loci (84). Given that tolerance induction during metamorphosis is critical for a successful transition, it is perhaps not surprising that there is no effect of the sympathetic nervous system on the process. Much of the research to date suggests that the SNS often has an immunomodulatory role that could be too subtle to have an effect on such a crucial process.

Additional experiments in other anuran species (Rana esculenta and R. temporaria), using pharmacologic administration of neurotransmitters confirm the lack of influence of such neurotransmitters on allograft survival (71). In contrast, rejection of xenogenic skin grafts transplanted to R. esculenta was accelerated by repeated injections of propranolol and in some cases, retarded by atropine (a cholinergic agonist). It should be noted, however, that xenograft rejection in frogs is generally thought to involve innate and antibody-mediated immunity, rather than T-cells (85, 86).

4.3. Endocrine Effects on Immunity

When discussing neuroendocrine influences on immunity, we generally refer to two "arms" or routes by which information flows from the CNS to the immune system- the autonomic nervous system (discussed above) and the endocrine system. Most of the hormones studied in mammals are pituitary-derived, and some studies, most notably those from the lab of Louise Rollins-Smith, have examined the role of pituitary hormones in immunity in Xenopus, particularly during metamorphosis.

4.3.1. Hypophyseal axis hormones

Endocrine-immune interactions have a long history of study, with the immunosuppressive effects of glucocorticoids underpinning one of the classic hallmarks of a generalized stress response (87). The impact of these steroids on immunity (sometimes only seen with pharmacologic rather than physiological concentrations), remains an active area of research, and is now seen to be more complex than a simple immunosuppressive effect (88).

Glucocorticoids effect similar changes in the lymphoid system of amphibians as they do in mammals (e.g., thymic involution, loss of cortical lymphocytes, redistribution of lymphocytes (89)). Some of these effects may depend on the season when the hormone is administered experimentally (90), and the effect may vary by lymphoid organ (91). In Xenopus, corticosterone treatment in vitro inhibits PHA-induced proliferation of splenocytes (92), and high (pharmacologic) doses of hydrocortisone in vivo suppresses antibody response (91).

Prolactin (PRL) may be "immunopermissive" for lymphocyte proliferation since in initial experiments, incubation of Xenopus cell cultures with anti-chicken PRL antibodies suppressed proliferation of larval and adult splenocytes that had been stimulated with LPS, PHA, or Con A (Rollins-Smith and Cohen, unpublished). Similarly, preliminary studies with lymphocytes from the salamander, Ambystoma mexicanum, also revealed that anti-PRL antibodies inhibited PHA-induced mitogenesis in a dose-dependent fashion (Cohen, unpublished). Moreover, addition of PRL to culture of mitogen-stimulated axolotl lymphocytes was significantly enhancing. If these effects are confirmed, such a permissive role is consistent with PRL effects in mammals, and suggests a long phylogenetic history of this function (93).

4.3.2. Seasonal Effects on Immunity

Vertebrates of all classes are known to exhibit regular endocrine changes in association with reproductive and other seasonal cycles. There is now a substantial literature on seasonal variation in immunity in a variety of ectothermic species, much of which has been related to endocrine changes (for review, see (5)). Overall, there appears to be a winter-associated period of immunocompromise in anurans, which may have profound effects on survival of populations in terms of both exposure to pathogens during winter months and immunological memory across seasons (94, 95). Amphibian lymphoid organs exhibit seasonal morphological changes (96, 97). The thymus of at least one frog species (Rana temporaria) undergoes cyclical changes with maximal development occurring during the summer and involution in the winter (98-100); these changes are not due solely to changes in the ambient temperature (98, 101). Although there are some indications of functional differences (102, 103), relatively little has been done to examine the effects of the normal winter hibernation period (or its laboratory equivalent) on the anuran immune system. Given issues associated with climate change and amphibian "extinctions" (see below), there is a pressing need to expand our understanding of seasonal effects on immunity; Xenopus as the laboratory model is currently underutilized in this regard.

4.3.3. Metamorphosis and Immunity

Metamorphosis is driven by changes in circulating levels of many endocrine hormones, most notably triiodothyronine (T3) and thyroxine (T4) (104-106). Thyroxine appears to drive the terminal maturation of larval erythrocytes (51, 107) and the expansion of a separate adult erythrocyte population (108), but does not have any consistent effects on lymphocyte viability or proliferation (92).

Alteration of thyroid hormone levels alters the progression of metamorphosis and allows a dissection of the development of adult-type immunity in relation to normal metamorphosis. Such experiments, then, reveal the very essence of neuroendocrine-immune interactions. One thyroid-manipulation strategy is to administer sodium perchlorate, a goitrogen that blocks iodine uptake by the thyroid follicle cells (68) thereby preventing overt metamorphosis. Under such a blockade, some features of the immune system change in a manner comparable to normal (i.e., unblocked) control animals. These features include: expression of MHC class I antigens (64, 109); immigration and expansion of T-cell precursors in the thymus (110); and development of high titer IgY antibody production (111). These changes occurring during blockade of thyroid function are assumed to be thyroid-independent. Other morphologic and functional features of immunity do not change in perchlorate-blocked tadpoles, and thus are (directly or indirectly) thyroid dependent. For example, in blocked larvae: the thymus does not assume an adult-type morphology (112); splenic compartmentation and innervation by the SNS (described above) is dramatically delayed (62); and lymphocytes in the thymus and spleen do not achieve the expanded cell numbers characteristic of postmetamorphic adults (113, 114). Functionally, blocked larvae retain: larval-type tolerogenic responses to skin allografts (Cohen and Crosby, unpublished), larval patterns of antibody response to a specific hapten (111); and a lack of adult-type MHC Class II+ T cells in the periphery (113).

In addition to thyroid hormones, PRL, growth hormone, and corticosteroid levels increase during metamorphosis (104, 115-118). All of these hormones have been shown to be immunomodulatory in mammals (93, 119, 120), and some are also known to be immunomodulatory in amphibians (56, 67, 109).

As mentioned above, corticosteroid hormones (CH) can be immunosuppressive in adult frogs. In general, this also appears to be true for larvae: concentrations of corticosterone as low as 1-10 nM induce apoptosis of larval thymocytes and splenocytes (109, 121), a sensitivity that is comparable to that of adult lymphocytes (92, 109, 121). This sensitivity, coupled with the rise in hormone levels during metamorphosis, may be a major cause of the extensive die-off of larval splenocytes at this time (67), and thus critical in the turnover of larval cells believed to be necessary for post-metamorphic self-tolerance. Additionally, both corticosterone and aldosterone (concentrations of which also rise during metamorphosis) inhibit PHA-induced proliferation of both adult and larval lymphocytes, an effect that can be blocked with the CH-receptor antagonist, RU486 (67, 92, 109, 121, 122).

The effects of hypophysectomy (HypX) of tadpoles on their immune function during metamorphosis appear less profound than might be expected. Such HypX tadpoles continue to grow, can generally reject MHC-disparate grafts, and have no apparent delay in repopulation of an implanted thymus with host thymocytes (123-126). HypX tadpoles maintain the low larval pattern of MCH class I and II antigens, even in skin at 1 year of age (127) and, like control tadpoles, do not reject minor H-locus disparate grafts or grafts expressing organ-specific antigens (124, 125). HypX tadpoles also exhibit decreased lymphocyte numbers in both thymus and spleen (relative to age-matched intact controls) as well as inhibited proliferation of cells in the developing thymus (110, 128).

4.4. Heat shock proteins and neural-immune system interactions

Several years ago, the Cohen-Robert lab at the University of Rochester asked whether the hsp 70 and hap 90 families of heat shock proteins (hsps) play any role in the Xenopus defense system. Although hsps are typically induced by heat, cold, and glucose deprivation (hence their designation as "stress proteins"), our interest in them at that time focused on their possible ancestral roles in immunity. Immunological properties of gp96 and hsp70 have been conserved during vertebrate evolution. Molecular, biochemical, and serological characterization confirms extensive structural conservation of gp96 homologues in all vertebrates. Hsps limit protein aggregation, facilitate protein folding, and act as molecular chaperones in all species studied (129, 130).

In frogs and well as mammals, hsps can have profound affects on both innate (danger signal) and adaptive immunity (52, 131-133). A wide range of endogenous peptides associate in vivo with hsps released from necrotic cells (134). They potentially represent the antigenic repertoire of a particular cell (i.e., tumor, viral, and minor H-antigens). Immunization of Xenopus with homologous gp96 stimulates MHC-restricted thymus-dependent immunity against minor H-antigens in vivo (135). Further, soluble complexes of peptides and either gp96 or hsp70 purified from autologous murine (136) or frog (52, 132) tumors specifically immunize recipients against tumor challenges. Such immunity is abrogated by depletion of CD8+ T-cells or macrophages during priming (136), and of CD8+ or CD4+ T-cells during the effector phase. Gp96 alone (i.e., without peptide) has been demonstrated to enhance cytokine production and non-specific killing (132), as part of a non-specific immune response.

It is not unreasonable to assume that increased expression of such ancient and important molecules as hsp70 and gp96 might significantly influence immunity. Of relevance to our discussion of neural-immune system interactions in Xenopus are the recent and exciting observations from the Fleshner laboratory that, in rats, hsp72 could be induced by physical stressors (intense exercise, inescapable electric tail shock (137)); this upregulation had consequences in terms of several parameters of innate immunity. More recently, Fleshner et al. (138) reported a similar elevation of central and peripheral hsp72 following exposure of a rat to a cat predator (psychosocial stressor); this response could be blocked or attenuated by adrenalectomy). To the best of our knowledge, no one has studied whether hsp-peptide complexes play any role in the mediation of those changes in innate and adaptive immunity that are causally associated with either physical and/or psychosocial stressors. Xenopus could serve as a worthy model system for such studies

5. SPECULATIONS, APPLICATIONS, AND FUTURE DIRECTIONS

In Xenopus as in mammals, it is important that studies progress from their current state of phenomenology to those that are more mechanistic. In mammals, such a progression is exemplified by the work of Virginia Sanders and her colleagues. Following up on her classic denervation studies (139-141), Sanders began studying how ligation of beta2AR on B and T cells by catecholamines (23) might bring about modulated immune responses. She demonstrated that cells secreting Th1-type cytokines, but not cells secreting Th2-type cytokines, express the functional beta2AR that binds to catecholamine agonists and antagonists (23, 142). In response to beta2AR stimulation, the levels of Th1 cytokines produced are modulated (e.g., decreased IL-2 production by freshly isolated murine splenic CD4+ T-cells (23, 24, 143)). Clearly, anything that differentially regulates cytokine responses of the Th1 and Th2 variety has a potentially important impact on the ensuing immune response.

Sanders also investigated the function of beta2AR expressed on B cells and found that NE stimulation is necessary for the maintenance of an optimal primary and secondary Th2 cytokine-dependent antibody response in vivo (144). Depletion of NE in vivo decreases levels of antigen specific IgG1 production cell proliferation and germinal center formation. More recently, this group has reported that signaling through the beta2AR receptor increases expression of the critically important co-stimulatory molecule, CD86 or B7-2 (145, 146) both in vivo and in vitro. Stimulation of the B cell receptor, CD86, and the beta2-AR in concert modulates the level of IgG1 and IgE produced on a per B cell basis (147). Additional cell signaling studies have revealed insights into the mechanisms by which CD86 expression is regulated (148, 149). Thus, from simple ablation studies, we now have a progressive, step-by-step understanding of at least some of the pathways by which the sympathetic nervous system can influence immunity. Sadly, this systematic and thorough research is not yet typical of the field; many phenomena in the discipline are still awaiting similar characterization in conventional murine and human systems; for comparative studies, the field is wide open.

Approaching the study of neural-immune interactions from a comparative perspective allows for a variety of other questions to be addressed. For example, amphibians are at an interesting phylogenetic position in terms of immunity given their position at the tetrapod transition from aquatic to terrestrial lifestyle. It is reasonable to posit that leaving the water for land resulted in differences in the pathogenic spectrum and other immune challenges to which the first terrestrial tetrapods were exposed. If this is the case, then the Amphibia offer a prime model for examining the extent to which the neuroendocrine and immune systems have coevolved.

"Psychoneuroimmunology" is a compound word reflecting the complex interactions that define this field. In terms of evaluating the state of this interdisciplinary science as it has been applied to the Amphibia, clearly the "neuro" component is the best studied. As reviewed above, much of the available information concerns the effects of neuroendocrine manipulation on measures of immunity. The "psycho" (i..e., behavioral) component of this field offers significant potential for research. For example, studying hormonal (particularly corticosteroid) manipulation in an ethologically relevant fashion (e.g. physical or psychosocial stressors in nature) is one neglected area. Another is the applicability of the immunocompetence-handicap hypothesis (ICH) to amphibians. The ICH was originally developed to explain the maintenance of the often flamboyant sexual traits of male birds (150). Briefly, it suggests that traits such as bright plumage are promoted by testosterone and preferred by females as an indicator of male quality. The testosterone-dependence of the trait maintains a form of honesty in the signal if the higher levels of testosterone needed for optimal trait expression is also immunosuppressive- only a very high-quality male can afford to use an immunosuppressive hormone to exaggerate an attractive trait (one of the senior author's students has termed this more colloquially the "swimming with dumbbells" hypothesis- demonstrating one's fitness by performing under an additional handicap). While still open to verification, this hypothesis has been tested and found viable for both birds (150-152) and reptiles (153, 154); it has only been addressed in a very limited fashion with amphibians (155). Thus, it would be interesting to further examine whether the behavioral mate-attracting traits of male amphibians (e.g., calling) impose any sort of immune handicap.

Much of what has been published in psychoneuroimmunology has been derived from various laboratory measures of immunity. Whether these sometime subtle changes that result from some neuroendocrine perturbation have significant bearing on the health of the organism is often questionable. Thus, another substantive topic in need of further investigation in amphibians is the effects of neuroendocrine changes (whether pharmacologic, developmental, seasonal, or via environmental challenges) on infection and disease outcomes. Even as we progress toward a complete mechanistic understanding of the field, we need to keep in mind that the true measure of the relevance of a behavioral manipulation is how it affects the survival and normal function of an intact behaving animal in a real-world setting.

At present, we have very limited understanding of the true adaptive value of neural-immune crosstalk. The following section presents an area that may provide a framework for understanding exactly this issue.

5.1. The amphibian decline problem: applied comparative psychoneuroimmunology.

Ecology would not seem to be a prime area for input from psychoneuroimmunological research. There are, however, several areas of ecology that can be advanced by a better understanding of neural-immune interactions. One such area is the ICH mentioned above. Another is the worldwide decrease of populations and species of frogs and salamanders (156). This decline is beginning to receive considerable attention owing not only to concerns of conservation biologists, but also because these disappearing amphibians have been suggested to be the "canaries in the coal mine" for consequences of anthropogenic environmental changes including global warming. Several not mutually exclusive hypotheses have been advanced to explain the declines. These include the destruction of habitat where amphibians breed and grow, and the introduction of invasive exotic taxa that displace native species. At face value, these two explanations would not appear to involve psychoneuroimmunological considerations. However, they do involve what might be considered environmental stressors (including UV radiation, pollution, and/or global climate change) and costs of inflammatory responses have been demonstrated to be lower for at least one (albeit non-amphibian) exotic invader than a non-invasive congener, leading to speculation about the role of immunity in invasion (157, 158).

At least two pathogens, a Chytrid fungus (Batrachochytrium dendrobatidis) and iridoviruses (ranavirus, Ambystoma tigrinum virus, frog virus 3) are causally involved (159) in these population declines and extinctions. Although it is reasonable to propose that exogenously altered immunity contributes to the action of these (and other) infectious agents, this has not yet been tested directly in the lab or in the field. With respect to the fungus, this is not surprising since our knowledge of amphibian adaptive immunity to chytrids is basically nonexistent. We do know, however, that naturally produced antimicrobial skin peptides of frogs are capable of inhibiting growth of zoospores and mature fungal cells (160). Amphibian skin gland secretion of these peptides is regulated by the SNS (i.e., the catecholamines epinephrine and norepinephrine; (161-163). Chlorotriazine herbicides and similar agents used as pesticides decrease the intracellular content and release of dopamine and NE from PC12 cells, a cell line with neuronal characteristics, (164), and inhibit NE synthesis by suppressing the activity of dopamine-beta-hydroxylase (165). This leads to the intriguing suggestion that introduction of such compounds into the environment has impaired immune function in amphibian populations via altered SNS activity, resulting in deaths due to infection.

Our knowledge of anti-iridoviral immunity, at least in Xenopus, is further along than our understanding of anti-fungal immunity. Thanks to the work of Jacques Robert and colleagues at the University of Rochester, we now know that in addition to antimicrobial peptides (166) and NK cells (167) as components of its innate immune system, Xenopus uses CD8 T-cells, NK/T cells, and antibody to deal with laboratory-introduced infections with the iridoviruses, frog virus 3 (FV3; (168)). We also know that: x-irradiation increases mortality associated with FV3 infection (169); larval and metamorphosing frogs are much more susceptible infection with FV3 than are adults (169); and, as previously mentioned, metamorphosing frogs have a naturally down-regulated immune system, presumably to avoid immune responses to adult-specific antigens that are emerging during metamorphosis (51). Finally, we know that in amphibians, glucocorticoids are highly immunomodulatory, especially during metamorphosis (121). It is interesting to speculate that environmental stressors increase glucocorticoids in populations of wild amphibians. Although we've not directly tested this possibility in Xenopus, we do know that elevated resting levels of corticosteroids have been detected in toads (Buffo terrestris) collected from areas polluted by coal ash, and in mudpuppies (Necturus maculosus) exposed to organochlorine where maximal concentrations approximate those associated with the natural glucocorticoid-associated immunosuppression in Xenopus that occurs during metamorphosis (92, 170, 171). Furthermore, immunotoxicological studies have revealed the immunosuppressive capacity of various pesticides (e.g., atrazine, metribuzine, endosulfan, lindane, aldicarb, DDT, malathione, and dieldrin) singly and in combination in Xenopus and Rana (172, 173). Obviously, it is a big jump to conclude from these few studies that immunomodulatory pollutants and other man-made additions to the environment are contributing to the decline of amphibians by suppressing their capacities to fully respond to viruses and fungi, but at the very least, the aforementioned scattered observations delineate a raft of focused experiments that could exploit Xenopus as an ideal model system.

Clearly, psychoneuroimmune mechanisms are not the only explanation for our example of amphibian decline. Nevertheless there is considerable potential for a better understanding of the problem through the great explanatory power of a meta-disciplinary approach. Any or all of the observed environmental changes could be immunosuppressive owing to their action on the neuroendocrine system that in turn, negatively signals the immune system and increases susceptibility to fungal and/or viral pathogenicity, eventuating in a population decline (56). Given that as yet no single "smoking gun" causing the decline has been unequivocally identified, it seems reasonable to propose that there is an interaction of two or more of the above "stressors" (along with other as yet unidentified ones), via neuroendocrine pathways, to suppress amphibian immunity thereby increasing pathogenicity (174).

In conclusion, comparative studies of the mechanisms of neural-immune crosstalk in a variety of nonmammalian species will not only provide insight into their evolution, but may help in understanding the adaptive significance of the having of these two major homeostatic systems coordinate their efforts.

6. ACKNOWLEDGMENTS:

Research cited from the authors' laboratories has been supported by grants R37 HD-07901, RO1 CA-76312 and R01 AI-44022 from the NIH (NC), IRCEB #00138 from the NSF (NC), and DePauw University and the John and Janice Fisher Fund for Faculty Development (KSK)

7. REFERENCES

1. R. Ader: Psychoneuroimmunology. Academic Press, San Diego (1981)

 

2. R. Ader, D. L. Felten & N. Cohen: Psychoneuroimmunology, 2nd Edition. Academic Press, San Diego (1991)

 

3. R. Ader, D.L. Felten & N. Cohen: Psychoneuroimmunology, 3rd Edition. Academic Press, San Diego (2001)

 

4. R. Ader: Psychoneuroimmunology, 4th Edition. Academic Press, San Diego (2007)

 

5. N. Cohen & K. S. Kinney: A phylogenetic history of neural-immune interactions. In: Psychoneuroimmunology, 4th Edition. Ed: R. Ader. Academic Press, San Diego (2006)

 

6. D. M. Nance & V.M. Sanders: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun, 21, 736-745 (2007)

doi:10.1016/j.bbi.2007.03.008
http://dx.doi.org/10.1016/j.bbi.2007.03.008

7. R. Glaser, P. K. Kiecolt-Glaser, P. T. Marucha, R. C. MacCallum, B. F. Laskowski & W. B. Malarkey: Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry, 56, 450-456 (1999)

doi:10.1001/archpsyc.56.5.450
http://dx.doi.org/10.1001/archpsyc.56.5.450

8. R. H. Bonneau, D. A. Padgett & J. F. Sheridan: Twenty years of psychoneuroimmunology and viral infections in Brain, Behavior, and Immunity. Brain Behav Immun, 21, 273-280 (2007)

doi:10.1016/j.bbi.2006.10.004
http://dx.doi.org/10.1016/j.bbi.2006.10.004

9. J. Kiecolt-Glaser & R. Glaser: Stress and immune function in humans. In: Psychoneuroimmunology, 2nd Edition. Eds: R. Ader, D. L. Felten&N. Cohen. Academic Press, San Diego (1991)

 

10. R. Ader, D. Felten & N. Cohen: Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol, 30, 561-602 (1990)

doi:10.1146/annurev.pa.30.040190.003021
http://dx.doi.org/10.1146/annurev.pa.30.040190.003021

11. R. Glaser & J. Kiecolt-Glaser: Handbook of Human Stress and Immunity. Academic Press, New York (1994)

 

12. R.M. Gorczynski, S. Macrae & M. Kennedy: Factors involved in classical conditioning of antibody response in mice. In: Breakdown in Human Adaptation to Stress: Toward a Multidisciplinary Approach. Eds: R. Ballieux, R. Fielding&A. L'Abbate. Martinus Nijhof, Boston (1984)

 

13. R. Ader, K. Kelly, J. A. Moynihan, L. Grota & N. Cohen: Conditioned enhancement of antibody using antigen as the unconditioned stimulus. Brain Behav Immun, 7, 334-343 (1993)

doi:10.1006/brbi.1993.1033
http://dx.doi.org/10.1006/brbi.1993.1033

14. V. Ramirez-Amaya & F. Bermudez-Rattoni: Conditioned enhancement of antibody production is disrupted by insular cortex and amygdala but not hippocampal lesions. Brain Behav Immun, 13, 46-60 (1999)

doi:10.1006/brbi.1998.0547
http://dx.doi.org/10.1006/brbi.1998.0547

15. S.Y. Felten, D.L. Felten, D.L. Bellinger & J.A. Olschowka: Noradrenergic and peptidergic innervation of lymphoid organs. Cell Immunol, 52, (1992)

 

16. D.L. Felten, R.D. Jozefowicz & F.H. Netter: Netter's Atlas of Neuroscience. Saunders, (2003)

 

17. J.C. de la Torre: Standardization of the sucrose-potassium phosphate-glyoxylic acid histofluorescence method for tissue monoamines. Neurosci Lett, 17, 339-340 (1980)

doi:10.1016/0304-3940 (80)90047-6
http://dx.doi.org/10.1016/0304-3940 (80)90047-6

18. S. Y. Felten & J. Olschowka: Noradrenergic sympathetic innervation of the spleen 2. Tyrosine-hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosci Res, 18, 37-48 (1987)

doi:10.1002/jnr.490180108
http://dx.doi.org/10.1002/jnr.490180108

19. D. L. Felten, S. Y. Felten, S. L. Carlson, J. A. Olschowka & S. Livnat: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol, 135, S755-S765 (1985)

 

20. D. L. Bellinger, D. Lorton, T. D. Romano, J. A. Olschowka, S. Y. Felten & D. L. Felten: Neuropeptide innervation of lymphoid organs. Ann N Y Acad Sci, 594, 17-33 (1990)

doi:10.1111/j.1749-6632.1990.tb40464.x
http://dx.doi.org/10.1111/j.1749-6632.1990.tb40464.x

21. T. A. Romano, S. Y. Felten, D. L. Felten & J. A. Olschowka: Neuropeptide-Y innervation of the rat spleen - Another potential immunomodulatory neuropeptide. Brain Behav Immun, 5, 116-131 (1991)

doi:10.1016/0889-1591 (91)90011-X
http://dx.doi.org/10.1016/0889-1591 (91)90011-X

22. G. Fried, L. Terenius, E. Brodin, S. Efendic, G. Dockray, J. Fahrenkrug, M. Goldstein & T. Hokfelt: Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen: Biochemical and immunohistochemical evidence. Cell Tissue Res, 243, 495-508 (1986)

doi:10.1007/BF00218056
http://dx.doi.org/10.1007/BF00218056

23. V. M. Sanders, R. A. Baker, D. S. RamerQuinn, D. J. Kasprowicz, B. A. Fuchs & N. E. Street: Differential expression of the beta (2)-adrenergic receptor by Th1 and Th2 clones - Implications for cytokine production and B cell help. J Immunol, 158, 4200-4210 (1997)

 

24. V. M. Sanders, D. J. Kasprowicz, A. P. Kohm & M. A. Swanson: Neurotransmitter receptors on lymphocytes and other lymphoid cells. In: Psychoneuroimmunology, 3rd Edition. Eds: R. Ader, D. L. Felten&N. Cohen. Academic Press, San Diego (2001)

 

25. A. Munck & P.M. Guyre: Glucocorticoids and immune function. In: Psychoneuroimmunology, 2nd Edition. Eds: R. Ader, D. L. Felten&N. Cohen. Academic Press, San Diego (1991)

 

26. S. Dimitrov, T. Lange, H. L. Fehm & J. Born: A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun, 18, 368-374 (2004)

doi:10.1016/j.bbi.2003.09.014
http://dx.doi.org/10.1016/j.bbi.2003.09.014

27. E. Bernton, H. Bryant, J. Holaday & J. Dave: Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporine-A. Brain Behav Immun, 6, 394-408 (1992)

doi:10.1016/0889-1591 (92)90038-P
http://dx.doi.org/10.1016/0889-1591 (92)90038-P

28. A. Stephanou, P. Fitzharris, R. A. Knight & S. L. Lightman: Characteristics and kinetics of proopiomelanocortin messenger-RNA expression by human leukocytes. Brain Behav Immun, 5, 319-327 (1991)

doi:10.1016/0889-1591 (91)90027-8
http://dx.doi.org/10.1016/0889-1591 (91)90027-8

29. F. Spadaro & A. J. Dunn: Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immun, 4, 308-322 (1990)

doi:10.1016/0889-1591 (90)90034-N
http://dx.doi.org/10.1016/0889-1591 (90)90034-N

30. V. M. Sanders & R. H. Straub: Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun, 16, 290-332 (2002)

doi:10.1006/brbi.2001.0639
http://dx.doi.org/10.1006/brbi.2001.0639

31. B. Kruszewska, S. Y. Felten & J. A. Moynihan: Alterations in cytokine and antibody production following chemical sympathectomy in 2 strains of mice. J Immunol, 155, 4613-4620 (1995)

 

32. B. Kruszewska, D.L. Felten & J.A Moynihan: Changes in cytokine production and proliferation following chemical sympathectomy: Interactions with glucocorticoids. Brain Behav Immun, 12, 181-200 (1998)

 

33. J.E. Blalock: The immune system as the sixth sense. J Intern Med, 257, 126-138 (2005)

doi:10.1111/j.1365-2796.2004.01441.x
http://dx.doi.org/10.1111/j.1365-2796.2004.01441.x

34. J.E. Blalock & E.M. Smith: Conceptual development of the immune system as a sixth sense. Brain Behav Immun, 21, 23-33 (2007)

doi:10.1016/j.bbi.2006.09.004
http://dx.doi.org/10.1016/j.bbi.2006.09.004

35. E.M. Smith: Opioid peptides in immune cells. Adv Exp Med Biol, 521, 51-68 (2003)

 

36. D. L. Felten, N. Cohen, R. Ader, S. Y. Felten, S. L. Carlson & T.L. Roszman: Central neural circuits involved in neural-immune interactions. In: Psychoneuroimmunology, 2nd Edition. Eds: R. Ader, D. L. Felten&N. Cohen. Academic Press, San Diego (1991)

 

37. H. O. Besedovsky & A. Del Rey: Immune-neuro-endocrine interactions: facts and hypothesis. Endocr Rev64-102 (1996)

doi:10.1210/er.17.1.64
http://dx.doi.org/10.1210/er.17.1.64

38. K.D. Dunlap & D.R. Church: Interleukin-1ß reduces daily activity level in male lizards, Sceleporus occidentalis. Brain Behav Immun, 10, 68-73 (1996)

doi:10.1006/brbi.1996.0006
http://dx.doi.org/10.1006/brbi.1996.0006

39. R. Dantzer: Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol, 500, 399-411 (2004)

doi:10.1016/j.ejphar.2004.07.040
http://dx.doi.org/10.1016/j.ejphar.2004.07.040

40. R. Dantzer, R Schicho, I.T. Lippe & P Holzer: Interleukin-1β-induced sensitization of vagal afferent pathways to intragastric acid challenge: A novel experimental model of functional dyspepsia? Gastroenterology, 122, A34 (2002)

 

41. L.E. Goehler, J.K. Relton, D. Dripss, R. Kiechle, N. Tartaglia, S.F. Maier & L.R. Watkins: Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication. Brain Res Bull, 43, 357-364 (1997)

doi:10.1016/S0361-9230 (97)00020-8
http://dx.doi.org/10.1016/S0361-9230 (97)00020-8

42. S. F. Maier: Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav Immun, 17, 69-85 (2003)

doi:10.1016/S0889-1591 (03)00032-1
http://dx.doi.org/10.1016/S0889-1591 (03)00032-1

43. S. F. Maier & L. R. Watkins: Cytokines for psychologists: implications of bi-directional immune to brain communication for understanding behaviour, mood, and cognition. Psycholog Rev, 105, 83-107 (1998)

doi:10.1037/0033-295X.105.1.83
http://dx.doi.org/10.1037/0033-295X.105.1.83

44. S.J Hopkins & N.J Rothwell: Cytokines and the nervous system. I.: Expression and recognition. Trends Neurosci, 18, 83-88 (1995)

doi:10.1016/0166-2236 (95)93881-W
http://dx.doi.org/10.1016/0166-2236 (95)93881-W

45. M. Minami, T. Katayama & M. Satoh: Brain cytokines and chemokines: Roles in ischemic injury and pain. J Pharmacol Sci, 100, 461-470 (2006)

doi:10.1254/jphs.CRJ06005X
http://dx.doi.org/10.1254/jphs.CRJ06005X

46. N. Cohen: Amphibian transplantation reactions: A review. Am Zool, 11, 193-205 (1971)

 

47. B. Sammut, L. Du Pasquier, P. Ducoroy, V. Laurens, A. Marcuz & A. Tournefier: Axolotl MHC architecture and polymorphism. Eur J Immunol, 29, 2897-2907 (1999)

doi:10.1002/ (SICI)1521-4141 (199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2
http://dx.doi.org/10.1002/ (SICI)1521-4141 (199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2

48. M. F. Flajnik: The immune system of ectothermic vertebrates. Vet Immunol Immunopathol, 54, 145-150 (1996)

doi:10.1016/S0165-2427 (96)05685-1
http://dx.doi.org/10.1016/S0165-2427 (96)05685-1

49. M. J. Manning & J.D. Horton: RES structure and function of the Amphibia. In: The Reticuloendothelial System: Phylogeny and Ontogeny. Eds: N. Cohen&M. M. Sigel. Plenum Press, New York (1982)

 

50. N. Cohen & A. Koniski: Axolotl immunology: Lymphocytes, cytokines, and alloincompatibility reactions. Axolotl Newsletter, 23, 24-33 (1994)

 

51. L. Du Pasquier, J. Schwager & M. Flajnik: The immune system of Xenopus. Annu Rev Immunol, 7, 251-275 (1989)

 

52. J. Robert, J. Gantress, N. Cohen & G. D. Maniero: Xenopus as an experimental model for studying evolution of hsp-immune system interactions. Methods, 32, 42-53 (2004)

doi:10.1016/S1046-2023 (03)00186-5
http://dx.doi.org/10.1016/S1046-2023 (03)00186-5

53. H.R. Kobel: Genetics of Xenopus laevis. Methods Cell Biol, 36, 19-34 (1991)

 

54. K. S. Kinney, N. Cohen & S. Y. Felten: Noradrenergic and peptidergic innervation of the amphibian spleen: Comparative studies. Dev Comp Immunol, 18, 511-521 (1994)

doi:10.1016/S0145-305X (06)80005-4
http://dx.doi.org/10.1016/S0145-305X (06)80005-4

55. K. S. Kinney & N. Cohen: Increased splenocyte mitogenesis following sympathetic denervation in Xenopus laevis. Dev Comp Immunol, 29, 287-293 (2005)

doi:10.1016/j.dci.2004.08.001
http://dx.doi.org/10.1016/j.dci.2004.08.001

56. L. A. Rollins-Smith & N. Cohen: Hormones and the immune system of Amphibians. In: Amphibian Biology. Ed: H. Heatwole. Surrey Beatty and Sons, Chipping Norton, Australia (2003)

 

57. D. L. Felten, K. D. Ackerman, S. J. Wiegand & S. Y. Felten: Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res, 18, 28-36 (1987)

doi:10.1002/jnr.490180107
http://dx.doi.org/10.1002/jnr.490180107

58. S. Nilsson: Sympathetic innervation of the spleen of the cane toad, Bufo marinus. Comp Biochem Physiol, 61C, 133-139 (1978)

 

59. A. Zapata, A. Villena & E. L. Cooper: Direct contacts between nerve endings and lymphoid cells in the jugular body of Rana pipiens. Experientia, 38, 623-624 (1982)

doi:10.1007/BF02327085
http://dx.doi.org/10.1007/BF02327085

60. M. J. Manning: Histological organization of the spleen: Implications for immune functions in amphibians. Res Immunol, 142, 355-359 (1991)

doi:10.1016/0923-2494 (91)90091-V
http://dx.doi.org/10.1016/0923-2494 (91)90091-V

61. P.D. Nieuwkoop & J. Faber: Normal Table of Xenopus laevis (Daudin). Holland Publishing Co., Amsterdam (1967)

 

62. K. S. Kinney, S. Y. Felten & N. Cohen: Sympathetic innervation of the amphibian spleen: Developmental studies in Xenopus laevis. Dev Comp Immunol, 20, 51-59 (1996)

doi:10.1016/0145-305X (95)00036-S
http://dx.doi.org/10.1016/0145-305X (95)00036-S

63. R. H. Clothier, L. N. Ruben, M. Balls & L. Greenhalgh: Morphological and immunological changes in the spleen of Xenopus laevis during metamorphosis. Res Immunol, 142, 360-362 (1991)

doi:10.1016/0923-2494 (91)90092-W
http://dx.doi.org/10.1016/0923-2494 (91)90092-W

64. L. A. Rollins-Smith, M.F. Flajnik, P. Blair, A. T. Davis & W.F. Green: Expression of MHC class I antigens during ontogeny in Xenopus is metamorphosis-independent. Dev Comp Immunol, 18, S95 (1994)

doi:10.1016/0145-305X (94)90123-6
http://dx.doi.org/10.1016/0145-305X (94)90123-6

65. K. S. Kinney, S. Y. Felten & N. Cohen: Sympathetic nervous system regulation of lymphocyte responsiveness in Xenopus laevis. Abstr Psychoneuroimmunol Res Soc (1996)

 

66. K. S. Kinney, S. Y. Felten, J. D. Horton & N. Cohen: Chemical sympathectomy and thymectomy effects on splenic anatomy in the frog Xenopus laevis. Soc Neurosci Abstr940-945 (1993)

 

67. L. A. Rollins-Smith & N. Cohen: Metamorphosis: An immunologically unique period in the life of the frog. In: Metamorphosis/Postembryonic Reprogramming of Gene Expression in Amphibian and Insect Cells. Eds: L. J. Gilbert, B. G. Atkinson&J. Tata. Academic Press, London (1995)

 

68. C.C Capen: Mechanisms of chemical injury of the thyroid gland. Prog Clin Res, 387, 173-191 (1994)

 

69. A.B. Silva, D. Aw & D. B. Palmer: Evolutionary conservation of neuropeptide expression in the thymus of different species. Immunology, 118, 131-140 (2006)

doi:10.1111/j.1365-2567.2006.02351.x
http://dx.doi.org/10.1111/j.1365-2567.2006.02351.x

70. S. J. Jozefowski & B. Plytycz: Characterization of beta-adrenergic receptors in fish and amphibian lymphoid organs. Dev Comp Immunol, 22, 587-603 (1998)

doi:10.1016/S0145-305X (98)00029-9
http://dx.doi.org/10.1016/S0145-305X (98)00029-9

71. S. Jozefowski, A. Jozefowski, L Antkiewicz-Michaluk, B. Plytcyz & R. Seljelid: Neurotransmitter and opioid modulation of the amphibian transplantation immunity. In: Modulators of Immune Responses: The Evolutionary Trail. Eds: J. S. Stolen, T. C. Fletcher, C. J. Bayne, C. J. Secombes, J. T. Zelikoff, Twerdok&D. P. Anderson. SOS Publications, Fair Haven, NJ (1996)

 

72. R. Hodgson, R. H. Clothier, L. N. Ruben & M. Balls: The effects of α and ί adrenergic agents on spleen cell antigen binding in four amphibian species. Eur J Immunol, 8, 348-351 (1978)

doi:10.1002/eji.1830080511
http://dx.doi.org/10.1002/eji.1830080511

73. R. M. Hodgson, R. H. Clothier & M. Balls: Adrenoreceptors, cyclic nucleotides, and the regulation of spleen cell antigen binding in urodele and anuran amphibians. Eur J Immunol, 9, 289-293 (1979)

doi:10.1002/eji.1830090408
http://dx.doi.org/10.1002/eji.1830090408

74. R. H. Clothier, L. N. Ruben, R. O. Johnson, K. Parker, M. Sovak, L. Greenhalgh, E. E. Ooi & M. Balls: Neuroendocrine regulation of immunity: the effects of noradrenaline in Xenopus laevis, the South African clawed toad. Int J Neurosci, 62, 123-140 (1992)

 

75. R. H. Clothier, L. N. Ruben, K. Tran & M. Balls: Catecholamine regulation of and by immunity in Xenopus laevis. Dev Comp Immunol, 13, 441-442 (1989)

doi:10.1016/0145-305X (89)90169-9
http://dx.doi.org/10.1016/0145-305X (89)90169-9

76. M. Haberfeld, R. O. Johnson, L. N. Ruben, R. H. Clothier & S. Shiigi: Adrenergic modulation of apoptosis in splenocytes of Xenopus laevis in vitro. Neuroimmunomodulation, 6, 175-181 (1999)

doi:10.1159/000026379
http://dx.doi.org/10.1159/000026379

77. D. Lorton, D. Hewitt, D. L. Bellinger, S. Y. Felten & D. L. Felten: Noradrenergic reinnervation of the rat spleen following chemical sympathectomy with 6-hydroxydopamine - Pattern and time course of reinnervation. Brain Behav Immun, 4, 198-222 (1990)

doi:10.1016/0889-1591 (90)90023-J
http://dx.doi.org/10.1016/0889-1591 (90)90023-J

78. K. Miles, J. Quintans, E. Chelmicka-Schorr & B. G. W. Arnason: The sympathetic nervous system modulates antibody response to thymus-independent antigens. J Neuroimmunol, 1, 101-105 (1981)

doi:10.1016/0165-5728 (81)90012-6
http://dx.doi.org/10.1016/0165-5728 (81)90012-6

79. S. Livnat, S. Y. Felten, S. L. Carlson, D. L. Bellinger & D. L. Felten: Involvement of peripheral and central catecholamine systems in neural immune interactions. J Neuroimmunol, 10, 5-30 (1985)

doi:10.1016/0165-5728 (85)90031-1
http://dx.doi.org/10.1016/0165-5728 (85)90031-1

80. K. S. Madden: Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun, 17, (2003)

 

81. J. Moynihan, B. Kruszewska, K. Madden & T. Callahan: Sympathetic nervous system regulation of immunity. J Neuroimmunol, 147, 87-90 (2003)

doi:10.1016/j.jneuroim.2003.10.018
http://dx.doi.org/10.1016/j.jneuroim.2003.10.018

82. K. S. Madden, S. Y. Felten, D. L. Felten, P. R. Sundaresan & S. Livnat: Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav Immun, 3, 72-89 (1989)

doi:10.1016/0889-1591 (89)90007-X
http://dx.doi.org/10.1016/0889-1591 (89)90007-X

83. M. J. Manning, N. Donnelly & N. Cohen: Thymus dependent and thymus independent components of the amphibian immune system. In: Phylogeny of Thymus and Bone Marrow-Bursa Cells. Eds: R. K. Wright&E. L. Cooper. North Holland Publishing Co., Amsterdam (1976)

 

84. K. S. Kinney: Sympathetic innervation of the amphibian spleen: Structural and functional studies. Interdepartmental Neuroscience Program, University of Rochester School of Medicine and Dentistry, 199 (1995).

 

85. J.D. Horton, T.L Horton, P. Ritchie & C.A. Varley: Skin xenograft rejection in Xenopus: immunohistology and effect of thymectomy. Transplantation, 53, 473-476 (1992)

doi:10.1097/00007890-199202010-00039
http://dx.doi.org/10.1097/00007890-199202010-00039

86. S. G. Klinsey, M. T. Bailey, J. F. Sheridan, D. A. Padgett & R. Avitsur: Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain Behav Immun, 21, 458-466 (2007)

doi:10.1016/j.bbi.2006.11.001
http://dx.doi.org/10.1016/j.bbi.2006.11.001

87. H. Selye: The Stress of Life. McGraw-Hill, New York (1978)

 

88. S. F. Sorrells & R. M. Sapolsky: An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun, 21, 259-272 (2007)

doi:10.1016/j.bbi.2006.11.006
http://dx.doi.org/10.1016/j.bbi.2006.11.006

89. E. Garrido, R. P. Gomariz, J. Leceta & A. Zapata: Effects of dexamethasone on the lymphoid organs of Rana perezi. Dev Comp Immunol, 11, 375-384 (1987)

doi:10.1016/0145-305X (87)90081-4
http://dx.doi.org/10.1016/0145-305X (87)90081-4

90. E. Garrido, R. P. Gomariz, J. Leceta & A. Zapata: Different sensitivity to the dexamethasone treatment of the lymphoid organs of Rana perezi in 2 different seasons. Dev Comp Immunol, 13, 57-64 (1989)

doi:10.1016/0145-305X (89)90017-7
http://dx.doi.org/10.1016/0145-305X (89)90017-7

91. B. Plytcyz, E. Kusina & A. Jozkowicz: Effects of hydrocortisone on the lymphoid organs of Rana temporaria. Folia Histochem Cytobiol, 31, 129-132 (1993)

 

92. L. A. Rollins-Smith & P.J. Blair: The effects of corticosteroid hormones and thyroid hormones on lymphocyte viability and proliferation during development and metamorphosis of Xenopus laevis. Differentiation, 54, 155-160 (1993)

doi:10.1111/j.1432-0436.1993.tb01598.x
http://dx.doi.org/10.1111/j.1432-0436.1993.tb01598.x

93. K. W. Kelley, S. Arkins & Y. M. Li: Growth hormone, prolactin, and insulin-like growth factors - New jobs for old players - Introduction. Brain Behav Immun, 6, 317-326 (1992)

doi:10.1016/0889-1591 (92)90031-I
http://dx.doi.org/10.1016/0889-1591 (92)90031-I

94. E. L. Cooper, R.K. Wright, A.E. Klempau & C.T. Smith: Hibernation alters the frog's immune system. Cryobiology, 29, 615-631 (1992)

doi:10.1016/0011-2240 (92)90066-B
http://dx.doi.org/10.1016/0011-2240 (92)90066-B

95. G. D. Maniero & C. Carey: Changes in selected aspects of immune function in the leopard frog, Rana pipiens, associated with exposure to cold. J Comp Physiol B, Biochem Syst Environ Physiol, 167, 256-263 (1997)

doi:10.1007/s003600050072
http://dx.doi.org/10.1007/s003600050072

96. B. Plytcyz & H. Szarski: Inguinal bodies of some Bufo species. J Herpetol, 21, 236-237 (1987)

doi:10.2307/1564490
http://dx.doi.org/10.2307/1564490

97. A. H. Saad & B. Plytycz: Hormonal and nervous regulation of amphibian and reptilian immunity. Folia Biol-Karkow, 42, 63-78 (1994)

 

98. J. Bigaj & B. Plytcyz: Endogenous rhythm in the thymus gland of Rana temporaria (Morphological study). Thymus, 6, 369-373 (1984)

 

99. B. Plytcyz, J. Dulak, J. Bigaj & K. Janeczko: Annual cycle of mitotic activity in the thymus of the frog, Rana temporaria. Herpetopathologia, 2, 23-29 (1991)

 

100. A. J. Miodonski, J. Bigaj, J. Mika & B. Plytcyz: Season-specific thymic architecture in the frog Rana temporaria: SEM studies. Dev Comp Immunol, 20, 129-137 (1996)

doi:10.1016/0145-305X (96)00004-3
http://dx.doi.org/10.1016/0145-305X (96)00004-3

101. A. Zapata, A. Varas & M. Torroba: Seasonal variations in the immune system of lower vertebrates. Immunol Today, 13, 142-147 (1992)

doi:10.1016/0167-5699 (92)90112-K
http://dx.doi.org/10.1016/0167-5699 (92)90112-K

102. M. Hussein, N. Badir, S. Zada, R. el Ridi & W. Zahran: Effect of seasonal changes on immune system of the toad, Bufo regularis. Bull Fac Sci Cairo Univ, 52, 181-192 (1984)

 

103. A. H. Saad & W. Ali: Seasonal changes in humoral immunity and blood thyroxine levels in the toad, Bufo regularis. Zoolog Sci, 9, 349-356 (1992)

 

104. B. White & C.S Nicoll: Hormonal control of amphibian metamorphosis. In: Metamorphosis: A Problem in Developmental Biology. Eds: L. Gilbert&E. Frieden. Plenum Press, New York (1981)

 

105. S. Kikuyama, K. Kawamura, S. Tanaka & Yamamoto: Aspects of amphibian metamorphosis: hormonal control. Int Rev Cytol, 145, 105-148 (1993)

 

106. J. Leloup & M Buscaglia: La triiodothyronine, hormone de la métamorphose des Amphibiens. Compte Rendu L'Acad Sci, Paris, 84D, 2261-2263 (1977)

 

107. V.A. Galton & D. St. Germain: Putative nuclear triiodothyronine receptors in tadpole erythrocytes during metamorphic climax. Endocrinology, 116, 99-104 (1985)

 

108. M.F. Flajnik & L. Du Pasquier: MHC class I antigens as surface markers of adult erythrocytes during the metamorphosis of Xenopus. Dev Biol, 128, 198-206 (1988)

doi:10.1016/0012-1606 (88)90282-5
http://dx.doi.org/10.1016/0012-1606 (88)90282-5

109. L. A. Rollins-Smith: Metamorphosis and the amphibian immune system. Immunol Rev, 166, 221-230 (1998)

doi:10.1111/j.1600-065X.1998.tb01265.x
http://dx.doi.org/10.1111/j.1600-065X.1998.tb01265.x

110. L. A. Rollins-Smith, P. J. Blair & A. T. Davis: Thymus ontogeny in frogs: T-cell renewal at metamorphosis. Dev Immunol, 2, 207-213 (1992)

 

111. E. Hsu & L. Du Pasquier: Ontogeny of the immune system in Xenopus: II. Antibody repertoire differences between larvae and adults. Differentiation, 28, 116-122 (1984)

 

112. R. H. Clothier & M. Balls: Structural changes in the thymus glands of Xenopus laevis during development. In: Metamorphosis. Eds: M. Balls&M. Bownes. Clarendon Press, Oxford (1985)

 

113. L. A. Rollins-Smith & P.J. Blair: Expression of class II major histocompatibility complex antigens on adult T-cells in Xenopus is metamorphosis dependent. Dev Immunol, 1, 97-104 (1990)

 

114. L. A. Rollins-Smith & P. Blair: Contribution of ventral blood island mesoderm to hematopoiesis in postmetamorphic and metamorphosis-inhibited Xenopus laevis. Dev Biol, 142, 178-183 (1990)

doi:10.1016/0012-1606 (90)90161-B
http://dx.doi.org/10.1016/0012-1606 (90)90161-B

115. G. Jaudet & J. Hatey: Variations in aldosterone and corticosterone plasma levels during metamorphosis in Xenopus laevis tadpoles. Gen Comp Endocrinol, 56, 59-65 (1984)

doi:10.1016/0016-6480 (84)90061-3
http://dx.doi.org/10.1016/0016-6480 (84)90061-3

116. S. Kikuyama, M.R. Suzuki & S. Iwamuro: Elevation of plasma aldosterone levels in tadpoles at metamorphic climax. Gen Comp Endocrinol, 63, 186-190 (1986)

doi:10.1016/0016-6480 (86)90155-3
http://dx.doi.org/10.1016/0016-6480 (86)90155-3

117. G. Clemons & C.S Nicoll: Development of a preliminary application of a homologous radioimmunoassay for bullfrog prolactin. Gen Comp Endocrinol, 32, 531-535 (1977)

doi:10.1016/0016-6480 (77)90237-4
http://dx.doi.org/10.1016/0016-6480 (77)90237-4

118. L. Buckbinder & D.D. Brown: Expression of Xenopus laevis prolactin and thyrotropin genes during metamorphosis. Proc Natl Acad Sci U S A, 90, 3820-3824 (1993)

doi:10.1073/pnas.90.9.3820
http://dx.doi.org/10.1073/pnas.90.9.3820

119. K. S. Madden & D. L. Felten: Experimental basis for neural-immune interactions. Physiol Rev, 75, 77-106 (1995)

 

120. K. Dorshkind & N.D. Horseman: The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev, 21, 292-312 (2000)

doi:10.1210/er.21.3.292
http://dx.doi.org/10.1210/er.21.3.292

121. L. A. Rollins-Smith, K. S. Barker & A. T. Davis: Involvement of glucocorticoids in the reorganization of the amphibian immune system at metamorphosis. Dev Immunol, 5, 145-152 (1997)

 

122. M. Marx, L. N. Ruben, C. Nobis & D. Duffy: Compromised T-cell regulatory functions during anuran metamorphosis: The role of corticosteroids. Prog Clin Biol Res, 233, 129-140 (1987)

 

123. L.A. Rollins & N. Cohen: On tadpoles, transplantation, and tolerance. In: Development and Differentiation of Vertebrate Lymphocytes. Ed: J. D. Horton. Elsevier/North Holland, Amsterdam (1980)

 

124. L. A. Rollins-Smith & N. Cohen: Self-pituitary grafts are not rejected by frogs deprived of their pituitary anlagen as embryos. Nature, 299, 820-821 (1982)

doi:10.1038/299820a0
http://dx.doi.org/10.1038/299820a0

125. M. Maéno & C. Katagiri: Elicitation of weak immune response in larval and adult Xenopus laevis by allografted pituitary. Transplantation, 38, 251-255 (1984)

 

126. L. A. Rollins-Smith, A. T. Davis & L. K. Reinert: Pituitary involvement in T cell renewal during development and metamorphosis of Xenopus laevis. Brain Behav Immun, 14, 185-197 (2000)

doi:10.1006/brbi.1999.0569
http://dx.doi.org/10.1006/brbi.1999.0569

127. L. A. Rollins-Smith, A. T. Davis & L.K. Reinert: Effects of early hypophysectomy on development of the immune system of Xenopus laevis. Dev Comp Immunol, 21, 152 (1997)

doi:10.1016/S0145-305X (97)88626-0
http://dx.doi.org/10.1016/S0145-305X (97)88626-0

128. J.B. Turpen & P.B. Smith: Precursor immigration and thymocyte succession during larval development and metamorphosis in Xenopus. J Immunol, 142, 41-44 (1989)

 

129. J.P. Hendrick & F.U. Hartl: Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem, 62, 349-375 (1993)

doi:10.1146/annurev.bi.62.070193.002025
http://dx.doi.org/10.1146/annurev.bi.62.070193.002025

130. S. Lindquist & E.A. Craig: The heat shock proteins. Annu Rev Genet, 22, 631-677 (1988)

doi:10.1146/annurev.ge.22.120188.003215
http://dx.doi.org/10.1146/annurev.ge.22.120188.003215

131. J. Robert, A. Menoret, P. K. Srivastava & N. Cohen: Immunological properties of heat shock proteins are phylogenetically conserved. In: Phylogenetic Perspectives on the Vertebrate Immune System. (2001)

 

132. J. Robert, N. Cohen, G. D. Maniero, A. Goyos, H. Morales & J. Gantress: Evolution of the inmunomodulatory role of the heat shock protein gp96. Cell Mol Biol, 49, 263-275 (2003)

 

133. P.K. Srivastava, A. Menoret, S. Basu, R.J. Binder & K.L. McQuade: Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world. Immunity, 8, 657-665 (1998)

doi:10.1016/S1074-7613 (00)80570-1
http://dx.doi.org/10.1016/S1074-7613 (00)80570-1

134. P. Srivastava: Peptide-binding heat shock proteins in the endoplasmic reticulum: Role in immune response to cancer and in antigen presentation. Adv Cancer Res, 62, 152-177 (1993)

 

135. J. Robert, J. Gantress, L. Rau, A. Bell & N. Cohen: Minor histocompatibility antigen-specific MHC-restricted CD8 T cell responses elicited by heat shock proteins. J Immunol, 168, 1697-1703 (2002)

 

136. R. Suto & P.K. Srivastava: A mechanism for the specfic immunogenicity of heat-shock protein-chaperoned peptides. Science, 269, 1585-1588 (1995)

doi:10.1126/science.7545313
http://dx.doi.org/10.1126/science.7545313

137. J. Campisi & M. Fleshner: Role of extracellular HSP72 in acute stress-induced potentiation of innate immunity in active rats. J Appl Ecol, 94, 43-52 (2002)

 

138. M. Fleshner, J. Campisi, L. Amiri & D.M. Diamond: Cat exposure induces both intra- and extracellular Hsp72, the role of adrenal hormones. Psychoneuroendocrinology, 29, 1132-1152 (2004)

doi:10.1016/j.psyneuen.2004.01.007
http://dx.doi.org/10.1016/j.psyneuen.2004.01.007

139. K. S. Madden, S. Y. Felten, D. L. Felten, C. A. Hardy & S. Livnat: Sympathetic nervous system modulation of the immune system 2. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmunol, 49, 67-75 (1994)

doi:10.1016/0165-5728 (94)90182-1
http://dx.doi.org/10.1016/0165-5728 (94)90182-1

140. K. S. Madden, J. A. Moynihan, G. J. Brenner, S. Y. Felten, D. L. Felten & S. Livnat: Sympathetic nervous system modulation of the immune system 3. Alterations in T-cell and B-cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol, 49, 77-87 (1994)

doi:10.1016/0165-5728 (94)90183-X
http://dx.doi.org/10.1016/0165-5728 (94)90183-X

141. G. J. Brenner, S. Y. Felten, D. L. Felten & J. A. Moynihan: Sympathetic nervous system modulation of tumor metastases and host defense mechanisms. J Neuroimmunol, 37, 191-201 (1992)

doi:10.1016/0165-5728 (92)90003-4
http://dx.doi.org/10.1016/0165-5728 (92)90003-4

142. D. S. Ramer-Quinn, R. A. Baker & V. M. Sanders: Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor - A mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol, 159, 4857-4867 (1997)

 

143. A. P. Kohm & V.M. Sanders: Norepinephrine and beta-2-adrenergic receptor stimulation regulates CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev, 53, 487-525 (2001)

 

144. A. P. Kohm & V. M. Sanders: Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol, 162, 5299-5308 (1999)

 

145. A. P. Kohm, A. Mozaffarian & V. M. Sanders: B cell receptor- and beta (2)-adrenergic receptor-induced regulation of b7-2 (CD86) expression in B cells. J Immunol, 168, 6314-6322 (2002)

 

146. V. M. Sanders: Interdisciplinary research: Noradrenergic regulation of adaptive immunity. Brain Behav Immun, 20, 1-8 (2006)

doi:10.1016/j.bbi.2005.07.004
http://dx.doi.org/10.1016/j.bbi.2005.07.004

147. D. J. Kasprowicz, A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. Sharpe & V. M. Sanders: Stimulation of the B cell receptor, CD86 (B7-2), and the beta (2)-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol, 165, 680-690 (2000)

 

148. J. R. Podojil & V.M. Sanders: Selective regulation of mature IgG1 transcription by CD86 and beta-2-adrenergic receptor stimulation. J Immunol, 170, 5143-5151 (2003)

 

149. J. R. Podojil, N. W. Kin & V.M. Sanders: CD86 and beta2-adrenergic-receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3 -IgH enhancer in B cells. J Biol Chem, 279, 23394-23404 (2004)

doi:10.1074/jbc.M313096200
http://dx.doi.org/10.1074/jbc.M313096200

150. I. Fostad & A.J. Karter: Parasites bright males, and the immunocompetence handicap. Am Nat, 139, 603-633 (1992)

doi:10.1086/285346
http://dx.doi.org/10.1086/285346

151. P. Deviche & L. Cortez: Androgen control of immunocompetence in the male house finch, Carpodacus mexicanus Muller. J Exp Biol, 208, 1287-1295 (2005)

doi:10.1242/jeb.01531
http://dx.doi.org/10.1242/jeb.01531

152. N.T. Owen-Ashley, D. Hasselquist & J.C. Wingfield: Androgens and the immunocompetence handicap hypothesis: Unraveling direct and indirect pathways of immunosuppression in song sparrows. Am Nat, 164, 490-505 (2004)

doi:10.1086/423714
http://dx.doi.org/10.1086/423714

153. A. Oppliger, M.S. Giorgi, A. Conelli, M. MNembrini & H.B. John-Adler: Effect of testosterone on immunocompetence, parasite load, and metabolism in the common wall lizard (Podarcis muralis). Can J Zool, 82, 1713-1719 (2004)

doi:10.1139/z04-152
http://dx.doi.org/10.1139/z04-152

154. S. Berger, L. B. Martin Ii, M. Wikelski, L. M. Romero, E. K. V. Kalko, M. N. Vitousek & T. Rodl: Corticosterone suppresses immune activity in territorial Galápagos marine iguanas during reproduction. Horm Behav, 47, 419-429 (2005)

doi:10.1016/j.yhbeh.2004.11.011
http://dx.doi.org/10.1016/j.yhbeh.2004.11.011

155. M. R. Forbes, D. L. McRuer & D. Shutler: White blood cell profiles of breeding American toads (Bufo americanus) relative to sex and body size. Comparative Clinical Pathology, 15, 155-159 (2006)

doi:10.1007/s00580-006-0623-5
http://dx.doi.org/10.1007/s00580-006-0623-5

156. J.P. Collins, N. Cohen, E.W. Davidson, J.E. Longcore & A. Storfer: Meeting the challenge of amphibian declines with an interdisciplinary research program. In: Declining Amphibians, A United States' Response to the Global Problem. Ed: M. Lanoo. University of California Press, Berkely, CA (2005)

 

157. K.A. Lee & K.C. Klasing: A role for immunology in invasion biology. Trends Ecol Evol, 19, 523-529 (2004)

doi:10.1016/j.tree.2004.07.012
http://dx.doi.org/10.1016/j.tree.2004.07.012

158. K.A. Lee, L. B. Martin Ii & M.C. Wikelski: Responding to inflammatory challenges is less costly for a successful avian invader, the house sparrow (Passer domesticus), than its less-invasive congener. Oecologia, 145, 244-251 (2005)

doi:10.1007/s00442-005-0113-5
http://dx.doi.org/10.1007/s00442-005-0113-5

159. C. Carey, N. Cohen & L. Rollins-Smith: Amphibian declines: An immunological perspective. Dev Comp Immunol, 23, 459-472 (1999)

doi:10.1016/S0145-305X (99)00028-2
http://dx.doi.org/10.1016/S0145-305X (99)00028-2

160. L. A. Rollins-Smith, J. K. Doersam, J. E. Longcore, S. K. Taylor, J. C. Shamblin, C. Carey & M. A. Zasloff: Antimicrobial peptide defenses against pathogens associated with global amphibian declines. Dev Comp Immunol, 26, 63-72 (2002)

doi:10.1016/S0145-305X (01)00041-6
http://dx.doi.org/10.1016/S0145-305X (01)00041-6

161. B.J. Benson & M.E. Hadley: In vitro characterization of adrenergic receptors controlling skin gland secretion in two anurans Rana pipiens and Xenopus laevis. Comp Biochem Physiol, 30, 857-864 (1969)

doi:10.1016/0010-406X (69)90040-1
http://dx.doi.org/10.1016/0010-406X (69)90040-1

162. G.J. Dockray & C.R. Hopkins: Caerulein secretion by dermal glands in Xenopus laevis. J Cell Biol, 64, 724-733 (1975)

doi:10.1083/jcb.64.3.724
http://dx.doi.org/10.1083/jcb.64.3.724

163. C. Holmes & M. Balls: In vitro studies on the control of myoepithelial cell contractions in the granular glands of Xenopus laevis skin. Gen Comp Endocrinol, 36, 255-263 (1978)

doi:10.1016/0016-6480 (78)90032-1
http://dx.doi.org/10.1016/0016-6480 (78)90032-1

164. P.C. Das, W.K. McElroy & R.L. Cooper: Differential modulation of catecholamines by chlorotriazine herbicides in pheochromocytoma (PC12) cells in vitro. Toxicological Science, 56, 324-331 (2000)

doi:10.1093/toxsci/56.2.324
http://dx.doi.org/10.1093/toxsci/56.2.324

165. J.M. Goldman, T.E. Stoker, R.L. Cooper, W.K. McElroy & J.F. Hein: Blockage of ovulation in the rat by the fungicide sodium N-methyldithiocarbamate: Relationship between effects on the luteinizing hormone surge and alterations in hypothalamic catecholamines. Neurotoxicol Teratol, 16, (1994)

 

166. V. G. Chinchar, J. Wang, G. Murti, C. Carey & L. Rollins-Smith: Inactivation of frog virus 3 and channel catfish virus by esculentin-2p and ranatuerin-2p, two antimicrobial peptides isolated from frog skin. Virology, 288, 351-357 (2001)

doi:10.1006/viro.2001.1080
http://dx.doi.org/10.1006/viro.2001.1080

167. T. L. Horton, R. Stewart, N. Cohen, L. Rau, P. Ritchie, M. D. Watson, J. Robert & J. D. Horton: Ontogeny of Xenopus NK cells in the absence of MHC class I antigens. Dev Comp Immunol, 27, 715-726 (2003)

doi:10.1016/S0145-305X (03)00040-5
http://dx.doi.org/10.1016/S0145-305X (03)00040-5

168. J. Gantress, G. D. Maniero, N. Cohen & J. Robert: Development and characterization of a model system to study amphibian immune responses to iridoviruses. Virology, 311, 254-262 (2003)

doi:10.1016/S0042-6822 (03)00151-X
http://dx.doi.org/10.1016/S0042-6822 (03)00151-X

169. J. Robert, H. Morales, W. Buck, N. Cohen, S. Marr & J. Gantress: Adaptive immunity and histopathology in frog virus 3-infected Xenopus. Virology, 332, 667-675 (2005)

doi:10.1016/j.virol.2004.12.012
http://dx.doi.org/10.1016/j.virol.2004.12.012

170. A. D. Gendron, C.A Bishop, R. Fortin & A. Hontela: In vivo testing of the functional integrity of the corticosterone-producing axis in mudpuppy (Amphibia) exposed to chlorinated hydrocarbons in the wild. Environ Toxicol Chem, 16, 1694-1706 (1997)

doi:10.1897/1551-5028 (1997)016<1694:IVTOTF>2.3.CO;2
http://dx.doi.org/10.1897/1551-5028 (1997)016<1694:IVTOTF>2.3.CO;2

171. K. S. Barker, A. T. Davis, B. Li & L. A. Rollins-Smith: In vitro studies of spontaneous and corticosteroid-induced apoptosis of lymphocyte populations from metamorphosing frogs RU486 inhibition. Brain Behav Immun, 11, 119-131 (1997)

doi:10.1006/brbi.1997.0489
http://dx.doi.org/10.1006/brbi.1997.0489

172. M. S. Christin, L. Menard, A. D. Gendron, S. Ruby, D. Cyr, D. J. Marcogliese, L. Rollins-Smith & M. Fournier: Effects of agricultural pesticides on the immune system of Xenopus laevis and Rana pipiens. Aquat Toxicol, 67, 33-43 (2004)

doi:10.1016/j.aquatox.2003.11.007
http://dx.doi.org/10.1016/j.aquatox.2003.11.007

173. M.K. Gilbertson, G.D. Haffner, K.G. Drouillard, A. Albert & B. Dixon: Immunosuppression in the northern leopard frog (Rana pipiens) induced by pesticide exposure. Environ Toxicol Chem, 22, 101-110 (2003)

doi:10.1897/1551-5028 (2003)022<0101:IITNLF>2.0.CO;2
http://dx.doi.org/10.1897/1551-5028 (2003)022<0101:IITNLF>2.0.CO;2

174. L. A. Rollins-Smith & J. M. Conlon: Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations. Dev Comp Immunol, 29, 589-598 (2005)

doi:10.1016/j.dci.2004.11.004
http://dx.doi.org/10.1016/j.dci.2004.11.004

175. J.T. Litchfield Jr.: A method for rapid graphic solution of time-per cent effect curves. J Pharmacol Exp Ther, 97, 399-408 (1949)

 

176. X. Chardonnens & L. Du Pasquier: Induction of skin allograft tolerance during metamorphosis of the toad, Xenopus laevis: a possible model for studying generation of self-tolerance to histocompatibility genes. Eur J Immunol, 3, 569-573 (1973)

doi:10.1002/eji.1830030909
http://dx.doi.org/10.1002/eji.1830030909

Abbreviations: 6-OHDA: 6-hydroxydopamine; AR: adrenergic receptor; CCK: cholecystokinin; CGRP: calcitonin gene-related peptide; CH: corticosteroid hormones; CNS: Central nervous system; Con A: Concanavalin A; DEX: dexamethasone; DTH: delayed-type hypersensitivity; FV3: frog virus 3; H: histocompatibility; HPA: hypothalamo-pituitary-adrenal; HPLC: High-performance liquid chromatography; Hsps: heat shock proteins; HypX: hypophysectomy; ICH: immunocompetence-handicap hypothesis; IgE: immunoglobulin E; IgG; immunoglobulin G; IgM: immunoglobulin M; IgY: immunoglobulin Y; IL-2: interleukin-2; KLH: keyhole limpet hemocyanin; LN: lymph node; LPS: lipopolysaccharide; MHC: major histocompatibility complex; NA: noradrenergic; NE: norepinephrine; NK: natural killer; NPY: Neuropeptide Y; PHA: phytohemagglutinin; PRL: prolactin; SNS: Sympathetic nervous system; SP: Substance P; SPG: Sucrose-potassium phosphate-glyoxylic acid; SRBC: sheep red blood cells; SyX: sympathectomy; T3: triiodothyronine; T4: thyroxine; TH: Tyrosine hydroxylase; TNP: trinitrophenol; VIP: Vasoactive intestinal peptide

Key Words: Amphibian, Psychoneuroimmunology, Endocrine, Neural-Immune Interactions, Comparative, Sympathetic Nervous System, Stress

Send correspondence to: Kevin S. Kinney, Dept of Biology, 210 Olin Building, Greencastle, IN 46135, Tel 765-658-6399, Fax: 765-658-4766, E-mail: kkinney@depauw.edu